Literature DB >> 16516574

Relation of T-wave alternans to regional left ventricular dysfunction and eccentric hypertrophy secondary to coronary heart disease.

Sanjiv M Narayan1, Joseph M Smith, Bruce D Lindsay, Michael E Cain, Victor G Dávila-Román.   

Abstract

Left ventricular (LV) hypertrophy and structural disease are associated with exaggerated repolarization dispersion and risk for cardiac arrest. We hypothesized that T-wave alternans (TWA) from the electrocardiogram, reflecting proarrhythmic repolarization dispersion, would increase with extent of eccentric LV hypertrophy and vary spatially with the distribution of myocardial scar. We studied 28 patients with coronary disease, systolic dysfunction, and nonsustained ventricular tachycardia. On echocardiography, 21 patients had wall motion abnormalities and 20 had LV hypertrophy (mass index > or =100 g/m(2)). TWA magnitude (voltage of alternation), which was computed spectrally during ventricular stimulation, varied linearly with LV mass index (p = 0.003). Spatially, positive TWA (magnitude > or =1.9 microV) in orthogonal electrocardiographic axes overlaid scar or wall motion abnormalities in corresponding echocardiographic segments (p <0.05 in x and y axes). After a follow-up of 35 +/- 13 months, positive TWA predicted the combined end point of death or sustained ventricular arrhythmias in all patients (p = 0.025), with a trend for those with echocardiographic LV hypertrophy (p = 0.058). In conclusion, in patients with systolic dysfunction due to coronary artery disease, TWA may indicate arrhythmic contributions from regional myocardial scar and eccentric LV hypertrophy.

Entities:  

Mesh:

Year:  2006        PMID: 16516574     DOI: 10.1016/j.amjcard.2005.09.127

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  T-wave alternans testing for ventricular arrhythmias.

Authors:  Sanjiv M Narayan
Journal:  Prog Cardiovasc Dis       Date:  2008 Sep-Oct       Impact factor: 8.194

2.  Assessment of physiological amplitude, duration, and magnitude of ECG T-wave alternans.

Authors:  Laura Burattini; Wojciech Zareba; Roberto Burattini
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-10       Impact factor: 1.468

3.  Scar tissue and microvolt T-wave alternans.

Authors:  Karin Kraaier; Marlon A G M Olimulder; Michel A Galjee; Pascal F H M van Dessel; Job van der Palen; Arthur A M Wilde; Marcoen F Scholten
Journal:  Int J Cardiovasc Imaging       Date:  2014-02-23       Impact factor: 2.357

4.  T-wave alternans and ST depression assessment identifies low risk individuals with ischemic cardiomyopathy in the absence of left ventricular hypertrophy.

Authors:  Daniel J Friedman; Seth R Bender; Steven M Markowitz; Bruce B Lerman; Peter M Okin
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-05-03       Impact factor: 1.468

5.  Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling.

Authors:  Sanjiv M Narayan; Jason D Bayer; Gautam Lalani; Natalia A Trayanova
Journal:  J Am Coll Cardiol       Date:  2008-11-25       Impact factor: 24.094

6.  Current developments in microvolt T-wave alternans.

Authors:  Beata Sredniawa; Agata Musialik-Lydka; Jacek Kowalczyk; Zbigniew Kalarus
Journal:  Indian Pacing Electrophysiol J       Date:  2006-10-01

7.  Suggestions to evaluate whether T-wave alternans is T-wave amplitude dependent.

Authors:  John E Madias
Journal:  Indian Pacing Electrophysiol J       Date:  2009-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.